Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

Alice Gottlieb, MD, PhD

Icahn School of Medicine at Mount Sinai
South Salem, NY, United States

Dr. Alice Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis She is triple boarded in dermatology, rheumatology and internal medicine. She is the recipient of numerous awards and is also the founder and President of the International Dermatology Outcome Measures (IDEOM) group. Through her research, Dr. Gottlieb has authored over 500 peer-reviewed articles has presented her research at more than 370 dermatology and rheumatology conferences around the world.

Currently, Dr. Gottlieb is Clinical Professor at Mount Sinai Union Square in New York while continuing her innovative clinical research in psoriasis, psoriatic arthritis, hidradenitis suppurativa, cutaneous lupus and vitiligo and other immune mediated disorders. She enjoys mentoring and teaching medical students, residents, and young faculty members.

Presentation(s):

  • 0564: Improvements in Patient Reported Outcomes Through 24 Weeks of Guselkumab Treatment in Participants with Active Psoriatic Arthritis and Inadequate Response and/or Intolerance to One Prior Tumor Necrosis Factor Inhibitor

    Sunday, October 26, 2025
    10:30 AM - 12:30 PM Central Time

    Disclosure(s): Bristol Myers Squibb: Grant/Research Support (Ongoing), Grants all paid to Mount Sinai School of Medicine until May 1, 2025 (Ongoing), Private Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Eli Lilly: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Johnson & Johnson: Grant/Research Support (Ongoing), Grants all paid to Mount Sinai School of Medicine until May 1, 2025 (Ongoing), Private Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Moonlake: Grant/Research Support (Ongoing), Grants all paid to Mount Sinai School of Medicine until May 1, 2025 (Ongoing); Novartis: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Oruka: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sun Pharma: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Takeda: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Teva: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB: Grant/Research Support (Ongoing), Grants all paid to Mount Sinai School of Medicine until May 1, 2025 (Ongoing), Private Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)